965 results on '"Wang, Youchun"'
Search Results
102. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
103. A fresh class of superconducting and hard pentaborides
104. Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
105. Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding
106. Characterization of a human–mouse chimeric monoclonal antibody targeting rabies virus glycoprotein
107. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16 : Alteration of Susceptibility to Antibody-Mediated Neutralization
108. In Vivo Bioluminescent Imaging of Marburg Virus in a Rodent Model
109. Corrigendum to “Functional characterization of AF-04, an afucosylated anti-MARV GP antibody” [BBA Mol. Basis Dis. 1870 (2024) 166964]
110. Structural and functional insights into MCR-2 mediated colistin resistance
111. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system
112. Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
113. Repeated Omicron infection alleviates SARS-CoV-2 immune imprinting
114. Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic
115. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
116. Systematic identification of hepatitis E virus ORF2 interactome reveals that TMEM134 engages in ORF2-mediated NF-κB pathway
117. Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
118. Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1.
119. Studies of a divergent genotype of hepatitis E virus from Chinese patients
120. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
121. High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell
122. Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion
123. A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice
124. Regulation and quality evaluation system for HIV diagnostics in China
125. Detection and assessment of infectivity of hepatitis E virus in urine
126. Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
127. Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines
128. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
129. Inhalable SARS-CoV-2 vaccines for single-dose dry-powder aerosol immunization and orchestrated mucosal/systemic immune responses
130. Retrospective immunogenicity analysis of seasonal flu H3N2 vaccines recommended in the past ten years using immunized animal sera
131. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
132. Development of a reporter gene assay for antibody dependent cellular cytotoxicity activity determination of anti‐rabies virus glycoprotein antibodies
133. Monkeypox virus quadrivalent mRNA vaccine induces antibody responses and cellular immunity and protects mice against Vaccinia virus
134. Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
135. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
136. Efficacy of an accelerated vaccination schedule against hepatitis E virus infection in pregnant rabbits
137. Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
138. Novel hKDR mouse model depicts the antiangiogenesis and apoptosis‐promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2
139. Stability and transmissibility of SARS‐CoV‐2 in the environment
140. Studies on structural, electronic and optical properties of nonlinear optical material Li-In-Se and Li-In-Te under high pressure
141. Spike-specific CXCR3+ TFH cells play a dominant functional role in supporting antibody responses in SARS-CoV-2 infection and vaccination
142. Long-Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus
143. Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75
144. Valuable antibody detection method for classifying hepatitis E virus genotypes
145. Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
146. Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B′ env molecular clones derived from infections in China
147. A new kinetic model for authigenic quartz formation under overpressure
148. TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein
149. Characterization of Chronic Hepatitis E Virus Infection in Immunocompetent Rabbits
150. ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.